These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38603508)

  • 21. Highly parallel oligonucleotide purification and functionalization using reversible chemistry.
    York KT; Smith RC; Yang R; Melnyk PC; Wiley MM; Turk CM; Ronaghi M; Gunderson KL; Steemers FJ
    Nucleic Acids Res; 2012 Jan; 40(1):e4. PubMed ID: 22039155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical Development of Therapeutic Oligonucleotides.
    Lundin KE; Gissberg O; Smith CIE; Zain R
    Methods Mol Biol; 2019; 2036():3-16. PubMed ID: 31410788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligonucleotide therapies for disorders of the nervous system.
    Khorkova O; Wahlestedt C
    Nat Biotechnol; 2017 Mar; 35(3):249-263. PubMed ID: 28244991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct oligonucleotide synthesis onto super-paramagnetic beads.
    Jensen MA; Akhras MS; Fukushima M; Pourmand N; Davis RW
    J Biotechnol; 2013 Sep; 167(4):448-53. PubMed ID: 23942380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical Synthesis of Oligonucelotide Sequences: Phosphoramidite Chemistry.
    Brazier J
    Methods Mol Biol; 2023; 2633():185-193. PubMed ID: 36853465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.
    Chen S; Le BT; Chakravarthy M; Kosbar TR; Veedu RN
    Sci Rep; 2019 Apr; 9(1):6078. PubMed ID: 30988454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromatographic approaches for the characterization and quality control of therapeutic oligonucleotide impurities.
    El Zahar NM; Magdy N; El-Kosasy AM; Bartlett MG
    Biomed Chromatogr; 2018 Jan; 32(1):. PubMed ID: 28869310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-phase synthesis of circular oligonucleotides.
    Pedroso E; Escaja N; Frieden M; Grandas A
    Methods Mol Biol; 2005; 288():101-26. PubMed ID: 15333900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tandem oligonucleotide synthesis on solid-phase supports for the production of multiple oligonucleotides.
    Pon RT; Yu S; Sanghvi YS
    J Org Chem; 2002 Feb; 67(3):856-64. PubMed ID: 11856029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New strategies for cyclization and bicyclization of oligonucleotides by click chemistry assisted by microwaves.
    Lietard J; Meyer A; Vasseur JJ; Morvan F
    J Org Chem; 2008 Jan; 73(1):191-200. PubMed ID: 18067317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs.
    Takakusa H; Iwazaki N; Nishikawa M; Yoshida T; Obika S; Inoue T
    Nucleic Acid Ther; 2023 Apr; 33(2):83-94. PubMed ID: 36735616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient Automated Solid-Phase Synthesis of DNA and RNA 5'-Triphosphates.
    Sarac I; Meier C
    Chemistry; 2015 Nov; 21(46):16421-6. PubMed ID: 26517040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of Kilogram-Scale Convergent Liquid-Phase Synthesis of Oligonucleotides.
    Zhou X; Kiesman WF; Yan W; Jiang H; Antia FD; Yang J; Fillon YA; Xiao L; Shi X
    J Org Chem; 2022 Feb; 87(4):2087-2110. PubMed ID: 34807599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualized Antisense Oligonucleotide Therapies: How to Approach the Challenge of Manufacturing These Oligos from a Chemistry, Manufacturing, and Control-Regulatory Standpoint.
    Lemaitre MM
    Nucleic Acid Ther; 2022 Apr; 32(2):101-110. PubMed ID: 34962152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorous methods for the synthesis of peptides and oligonucleotides.
    Miriyala B
    Top Curr Chem; 2012; 308():105-33. PubMed ID: 21972023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convergent Biocatalytic Mediated Synthesis of siRNA.
    Paul S; Gray D; Caswell J; Brooks J; Ye W; Moody TS; Radinov R; Nechev L
    ACS Chem Biol; 2023 Oct; 18(10):2183-2187. PubMed ID: 37061926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulating the activity of oligonucleotides by carbohydrate conjugation: solid phase synthesis of sucrose-oligonucleotide hybrids.
    Adinolfi M; De Napoli L; Di Fabio G; Iadonisi A; Montesarchio D
    Org Biomol Chem; 2004 Jul; 2(13):1879-86. PubMed ID: 15227540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.